Tonya Lane
University of Pittsburgh
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Tonya Lane.
Journal of Clinical Child and Adolescent Psychology | 2006
Jennifer S. Silk; Daniel S. Shaw; Erika E. Forbes; Tonya Lane; Maria Kovacs
This study tests a model of childrens emotion regulation (ER) as a moderator of the link between maternal depression and child internalizing problems. Participants were 78 children (ages 4 to 7), including 45 children of mothers with a history of childhood-onset depression (COD) and 33 children of mothers who had never been depressed. ER was assessed observationally during a laboratory mood induction. ER behaviors were empirically reduced into 3 categories: (a) negative focus on delay, (b) positive reward anticipation, and (c) behavioral distraction. Linear mixed models indicated that positive reward anticipation moderated the effects of maternal COD on childrens internalizing problems, particularly if mothers had current depressive symptoms. Findings suggest that generating positive affect in the face of a potential frustration may be a protective ER strategy for children at risk for depression.
The New England Journal of Medicine | 2015
Eric C. Donny; Rachel L. Denlinger; Jennifer W. Tidey; Joseph S. Koopmeiners; Neal L. Benowitz; Ryan Vandrey; Mustafa al'Absi; Steven G. Carmella; Paul M. Cinciripini; Sarah S. Dermody; David J. Drobes; Stephen S. Hecht; Joni Jensen; Tonya Lane; Chap T. Le; F. Joseph McClernon; Ivan D. Montoya; Sharon E. Murphy; Jason D. Robinson; Maxine L. Stitzer; Andrew A. Strasser; Hilary A. Tindle; Dorothy K. Hatsukami
BACKGROUND The Food and Drug Administration can set standards that reduce the nicotine content of cigarettes. METHODS We conducted a double-blind, parallel, randomized clinical trial between June 2013 and July 2014 at 10 sites. Eligibility criteria included an age of 18 years or older, smoking of five or more cigarettes per day, and no current interest in quitting smoking. Participants were randomly assigned to smoke for 6 weeks either their usual brand of cigarettes or one of six types of investigational cigarettes, provided free. The investigational cigarettes had nicotine content ranging from 15.8 mg per gram of tobacco (typical of commercial brands) to 0.4 mg per gram. The primary outcome was the number of cigarettes smoked per day during week 6. RESULTS A total of 840 participants underwent randomization, and 780 completed the 6-week study. During week 6, the average number of cigarettes smoked per day was lower for participants randomly assigned to cigarettes containing 2.4, 1.3, or 0.4 mg of nicotine per gram of tobacco (16.5, 16.3, and 14.9 cigarettes, respectively) than for participants randomly assigned to their usual brand or to cigarettes containing 15.8 mg per gram (22.2 and 21.3 cigarettes, respectively; P<0.001). Participants assigned to cigarettes with 5.2 mg per gram smoked an average of 20.8 cigarettes per day, which did not differ significantly from the average number among those who smoked control cigarettes. Cigarettes with lower nicotine content, as compared with control cigarettes, reduced exposure to and dependence on nicotine, as well as craving during abstinence from smoking, without significantly increasing the expired carbon monoxide level or total puff volume, suggesting minimal compensation. Adverse events were generally mild and similar among groups. CONCLUSIONS In this 6-week study, reduced-nicotine cigarettes versus standard-nicotine cigarettes reduced nicotine exposure and dependence and the number of cigarettes smoked. (Funded by the National Institute on Drug Abuse and the Food and Drug Administration Center for Tobacco Products; ClinicalTrials.gov number, NCT01681875.).
Journal of Family Psychology | 2007
Xin Feng; Daniel S. Shaw; Emily Moye Skuban; Tonya Lane
This study examined the stability of the child and maternal affective expression and maternal responsiveness and the mutual influence of child and maternal expression of emotion. The authors tested whether maternal depression and child problem behavior were associated with the pattern of emotional exchange within the mother-child dyads. The sample consisted of 69 mother-child dyads (children aged 2-5 years), with 32 of the mothers having childhood-onset depression. Mothers were mostly stable in their affective expression (positive and negative) and responsiveness, whereas children were only stable in positive expression. Within the dyads, mothers seemed to play a more important role in regulating childrens later emotional expression. Maternal depression was associated with concurrent maternal responsiveness and their reduced positive expression over time. Results are discussed in relation to the differential function of parental general positivity and responsiveness and the interpersonal transmission of emotional problems.
Electrophoresis | 2000
Amy Trout; Rajani Prasad; David Coffin; Andrea DiMartini; Tonya Lane; Cynthia R. Blessum; Neeta Khatter; James P. Landers
Transferrin, an iron transport protein found in serum and cerebrospinal fluid, is known to be microheterogeneous with respect to its carbohydrate and sialic acid content. The forms of transferrin deficient in sialic acid and/or carbohydrate, termed carbohydrate‐deficient transferrin (CDT), have been of clinical interest for almost two decades as a result of the initial finding that elevated CDT concentrations are associated with chronic, excessive alcohol abuse. We demonstrate the utility of capillary electrophoresis for examining the CDT sialoform profile via the direct electrophoresis of serum. The need for negligible preelectrophoresis sample preparation and absence of postelectrophoresis processing dramatically decreases analysis time compared to slab gel‐based separations. Using a fluorocarbon‐coated capillary containing a hydroxyethyl cellulose/borate buffer, the high resolution separation of serum components is effected in less than 30 min. Under these conditions, the beta region proteins (including transferrin) are well resolved from the alpha‐2 and gamma zone proteins in a window where the individual transferrin sialoforms can be detected. The usefulness of this method is demonstrated with the electrophoresis of serum from subjects known to be either nonalcoholic and alcoholic.
JAMA | 2018
Dorothy K. Hatsukami; Xianghua Luo; Joni Jensen; Mustafa al’Absi; Sharon S. Allen; Steven G. Carmella; Menglan Chen; Paul M. Cinciripini; Rachel L Denlinger-Apte; David J. Drobes; Joseph S. Koopmeiners; Tonya Lane; Chap T. Le; Scott J. Leischow; Kai Luo; F. Joseph McClernon; Sharon E. Murphy; Viviana Paiano; Jason D. Robinson; Herbert H. Severson; Christopher Sipe; Andrew A. Strasser; Lori G. Strayer; Mei Kuen Tang; Ryan Vandrey; Stephen S. Hecht; Neal L. Benowitz; Eric C. Donny
Importance The optimal temporal approach for reducing nicotine to minimally or nonaddictive levels in all cigarettes sold in the United States has not been determined. Objectives To determine the effects of immediate vs gradual reduction in nicotine content to very low levels and as compared with usual nicotine level cigarettes on biomarkers of toxicant exposure. Design, Setting, and Participants A double-blind, randomized, parallel-design study with 2 weeks of baseline smoking and 20 weeks of intervention was conducted at 10 US sites. A volunteer sample of daily smokers with no intention to quit within 30 days was recruited between July 2014 and September 2016, with the last follow-up completed in March 2017. Interventions (1) Immediate reduction to 0.4 mg of nicotine per gram of tobacco cigarettes; (2) gradual reduction from 15.5 mg to 0.4 mg of nicotine per gram of tobacco cigarettes with 5 monthly dose changes; or (3) maintenance on 15.5 mg of nicotine per gram of tobacco cigarettes. Main Outcomes and Measures Between-group differences in 3 co-primary biomarkers of smoke toxicant exposure: breath carbon monoxide (CO), urine 3-hydroxypropylmercapturic acid (3-HPMA, metabolite of acrolein), and urine phenanthrene tetraol (PheT, indicator of polycyclic aromatic hydrocarbons) calculated as area under the concentration-time curve over the 20 weeks of intervention. Results Among 1250 randomized participants (mean age, 45 years; 549 women [44%]; 958 [77%] completed the trial), significantly lower levels of exposure were observed in the immediate vs gradual reduction group for CO (mean difference, −4.06 parts per million [ppm] [95% CI, −4.89 to −3.23]; P < .0055), 3-HPMA (ratio of geometric means, 0.83 [95% CI, 0.77 to 0.88]; P < .0055), and PheT (ratio of geometric means, 0.88 [95% CI, 0.83 to 0.93]; P < .0055). Significantly lower levels of exposure were observed in the immediate reduction vs control group for CO (mean difference, −3.38 [95% CI, −4.40 to −2.36]; P < .0055), 3-HPMA (ratio of geometric means, 0.81 [95% CI, 0.75 to 0.88]; P < .0055), and PheT (ratio of geometric means, 0.86 [95% CI, 0.81 to 0.92]; P < .0055). No significant differences were observed between the gradual reduction vs control groups for CO (mean difference, 0.68 [95% CI, −0.31 to 1.67]; P = .18), 3-HPMA (ratio of geometric means, 0.98 [95% CI, 0.91 to 1.06]; P = .64), and PheT (ratio of geometric means, 0.98 [95% CI, 0.92 to 1.04]; P = .52). Conclusions and Relevance Among smokers, immediate reduction of nicotine in cigarettes led to significantly greater decreases in biomarkers of smoke exposure across time compared with gradual reduction or a control group, with no significant differences between gradual reduction and control. Trial Registration clinicaltrials.gov Identifier: NCT02139930
Contemporary clinical trials communications | 2018
Abid A. Kazi; Alyse Fazzi; Nicolle M. Krebs; Aimee J. Merchlinski; Brenda Kline; Susan Veldheer; John P. Richie; Jonathan Foulds; Tonya Lane; Eric C. Donny; Joshua E. Muscat
Investigational tobacco products, specifically variable nicotine content research cigarettes (SPECTRUM), are available through the National Institute of Drug Abuse Drug Supply Program. Randomized controlled trials using research cigarettes are intended to support tobacco regulatory science research. The current paper provides an in-depth look into managing research cigarettes for two multi-site clinical trials and the design of a computer-based Cigarette Management System (CMS). The paper provides guidance intended for any investigator using similar products on the operating procedures under Good Clinical Practice standards and describes features of the CMS. The CMS and procedures described have been field tested for the past three years and have dispensed over 160,000 cigarette packs to participants. The CMS can accommodate a range of practical issues with real-world study implementation making it a robust application that is scalable to any study.
Journal of Child Psychology and Psychiatry | 2007
Xin Feng; Daniel S. Shaw; Maria Kovacs; Tonya Lane; Flannery O'Rourke; Joseph H. Alarcon
Psychosomatics | 2001
Andrea DiMartini; Nancy L. Day; Mary Amanda Dew; Tonya Lane; Mary Grace Fitzgerald; Judy Magill; Ashokumar Jain
Alcoholism: Clinical and Experimental Research | 2001
Andrea DiMartini; Nancy L. Day; Tonya Lane; Amy T. Beisler; Mary Amanda Dew; Raymond Anton
Archive | 2012
Erin M. Ingoldsby; Elizabeth C. Shelleby; Tonya Lane; Daniel S. Shaw